FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240715E00032
1. Date of relevant event: 10/07/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02228
4. Name of listed corporation: QuantumPharm Inc. - P 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 3,415,568,761
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Lai
(Other names) Li Peng
10. Name of director (Chinese): 赖力鹏 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 120,129,801         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position120,129,8013.53
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position120,129,8013.52
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position32,315,661
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position87,814,140
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
SeveningBAlpha LimitedSertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsLPHappy Holding Limited99.00Y
Long position87,814,140
LPHappy Holding LimitedCoastal Building, Wickham's Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands赖力鹏100.00N
Long position87,814,140
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
LPHappy Family TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position87,814,140
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 方格24：由于行使超额配售权额外发行8,796,000股份，赖力鹏持有的股份比例改变。方格27：根据赖力鹏与SeveningBAlpha Limited签订的授权书，QuantumPharm Holdings Limited获授权行使由SeveningBAlpha Limited持有87,814,140股份所附带的投票权。赖力鹏于首次公开发售前员工持股计划中享有涉及32,315,661股份的购股权。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 15/07/2024
(dd/mm/yyyy)